Radiochemotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer
- PMID: 16705316
- PMCID: PMC2361266
- DOI: 10.1038/sj.bjc.6603076
Radiochemotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer
Comment on
-
Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison.Br J Cancer. 2005 Aug 8;93(3):279-86. doi: 10.1038/sj.bjc.6602696. Br J Cancer. 2005. PMID: 16012523 Free PMC article. Clinical Trial.
References
-
- Adelstein DJ, Li Y, Adams GL, Wagner Jr H, Kish JA, Ensley JF, Schuller DE, Forastiere AA (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresctable squamous cell head and neck cancer. J Clin Oncol 20: 92–98 - PubMed
-
- Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann T, Bamberg M, Wust P, Hinkelbein W, Wernecke KD (2005) Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated therapy alone in locally advanced head and neck cancer. J Clin Oncol 23: 1125–1135 - PubMed
-
- Dietl B, Schäfer C, Kölbl O (2005) Prognostische Wertigkeit der Zeitparameter in der adjuvanten Radiotherapie von HNO-Tumoren. Strahlenther Onkol 181: 800–807 - PubMed
-
- Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. New Engl J Med 349: 2091–2098 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
